Form 4 for BBIO BridgeBio Pharma, Inc.
Accepted 2026-06-24 18:05:29 ET · period of report 2026-06-22 · accession 0001470831-26-000627 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-24 18:05 | 2026-06-22 | BBIO | MCCORMICK FRANK | Dir | A - Grant | $0.00 | +3,990 | 10.6K | +61% | $0 |
| D | 2026-06-24 18:05 | 2026-06-22 | BBIO | MCCORMICK FRANK | Dir | A - Grant | $0.00 | +5,277 | 5,277 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-22 | A | A | 3,990 | $0.00 | 10,579 | D | — | — | (F1) Grant of restricted stock units ("RSUs") under the Issuer's 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan. The RSUs vest in full on June 22, 2027, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date. (F2) Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. (F3) The Reporting Person previously reported a transfer of 352,290 shares on a Form 4 filed June 25, 2024. The reported transfer did not occur, and no change in beneficial ownership took place at that time. The ownership amounts reported herein reflect the Reporting Person's correct holdings and the transfer described in Footnotes 4 and 5. (F4) Excludes 428,976 shares that were previously held directly by the Reporting Person and were transferred to the Reporting Person's trust account on June 3, 2026. |
| 2 | Derivative | Stock Option (Right to Buy) | 2026-06-22 | A | A | 5,277 | $0.00 | 5,277 | D | $68.92 · — to 2036-06-21 | 5,277 Common Stock | (F6) The shares underlying the stock option vest in full on June 22, 2027, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date. |